KORU Medical Systems, Inc. KRMD
Medical/Dental Instruments · data as of November 13, 2026
KORU Medical Systems, Inc. (KRMD) is a healthcare company listed in the US with a market value of about $160M. In the twelve months to September 30, 2026 it had revenue of $46M and net income of -$823382, a net margin of -1.8%.
Its overall Stock Analiz score is 1.4 out of 5 (weak). The strongest part is future growth (4/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of 11% a year, a 5-year average ROIC of -22%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 83% below the current price.
About KORU Medical Systems
KORU Medical Systems is listed in the US and classified in medical/dental instruments. Revenue went from $11M in 2015 to $41M in 2025, growth of about 13.8% a year. It was profitable in 3 of the last 10 years in our data. Its share count rose by 3% over three years (dilution for shareholders). It spends 11% of revenue on research and development.
Score: 1.4 / 5
Checks passed
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- Strong R&D investment or growth above 20%
- 5-year revenue growth above 8% a year
- More cash than debt, or low debt to equity
- Liabilities below 60% of assets
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
- 5-year average ROIC above 12%
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $46M | $41M | $34M | $29M | $28M | $23M | $24M | $23M | $17M | $12M | $12M |
| Net income | -$823382 | -$3M | -$6M | -$14M | -$9M | -$5M | -$1M | $564349 | $910570 | -$534999 | $782864 |
| Free cash flow | -$387369 | -$470112 | -$2M | -$6M | -$8M | -$5M | -$2M | $119446 | $1M | -$534741 | $2M |
| EPS (diluted) | $-0.02 | $-0.06 | $-0.13 | $-0.30 | $-0.19 | $-0.10 | $-0.03 | $0.01 | $0.02 | $-0.01 | $0.02 |
| Net margin | -1.8% | -6.4% | -18.0% | -48.2% | -31.1% | -19.4% | -5.0% | 2.4% | 5.2% | -4.3% | 6.4% |
| ROIC | — | -11.5% | -24.9% | -33.3% | -24.5% | -13.6% | -2.7% | 4.1% | 10.1% | -7.6% | 11.4% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Is KORU Medical Systems stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 83% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does KORU Medical Systems pay a dividend?
Not currently.
Is KORU Medical Systems a good stock to buy?
We do not give buy or sell advice. KORU Medical Systems scores 1.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.